PharmaCorp Files 2024 Year End Audited Financial Statements and MD&A
Summary by The Hamilton Spectator
6 Articles
6 Articles
All
Left
6
Center
Right

+5 Reposted by 5 other sources
PharmaCorp Files 2024 Year End Audited Financial Statements and MD&A
SASKATOON, Saskatchewan, April 22, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the filing on SEDAR+ of its audited financial statements together with associated MD&A for the year ended December 31,…
·Hamilton, Canada
Read Full ArticleCoverage Details
Total News Sources6
Leaning Left6Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage